Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- PMID: 32425950
- PMCID: PMC7205903
- DOI: 10.3389/fimmu.2020.00827
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Abstract
Background: The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed great threat to human health. T cells play a critical role in antiviral immunity but their numbers and functional state in COVID-19 patients remain largely unclear. Methods: We retrospectively reviewed the counts of T cells and serum cytokine concentration from data of 522 patients with laboratory-confirmed COVID-19 and 40 healthy controls. In addition, the expression of T cell exhaustion markers were measured in 14 COVID-19 cases. Results: The number of total T cells, CD4+ and CD8+ T cells were dramatically reduced in COVID-19 patients, especially in patients requiring Intensive Care Unit (ICU) care. Counts of total T cells, CD8+ T cells or CD4+ T cells lower than 800, 300, or 400/μL, respectively, were negatively correlated with patient survival. T cell numbers were negatively correlated to serum IL-6, IL-10, and TNF-α concentration, with patients in the disease resolution period showing reduced IL-6, IL-10, and TNF-α concentrations and restored T cell counts. T cells from COVID-19 patients had significantly higher levels of the exhausted marker PD-1. Increasing PD-1 and Tim-3 expression on T cells was seen as patients progressed from prodromal to overtly symptomatic stages. Conclusions: T cell counts are reduced significantly in COVID-19 patients, and the surviving T cells appear functionally exhausted. Non-ICU patients with total T cells counts lower than 800/μL may still require urgent intervention, even in the immediate absence of more severe symptoms due to a high risk for further deterioration in condition.
Keywords: COVID-19; SARS- CoV-2; T cell exhaustion; T cell reduction; cytokine strom.
Copyright © 2020 Diao, Wang, Tan, Chen, Liu, Ning, Chen, Li, Liu, Wang, Yuan, Feng, Zhang, Wu and Chen.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7205903/bin/fimmu-11-00827-g0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7205903/bin/fimmu-11-00827-g0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7205903/bin/fimmu-11-00827-g0003.gif)
Similar articles
-
IL-6 and CD8+ T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19.JCI Insight. 2020 Jul 9;5(13):e139024. doi: 10.1172/jci.insight.139024. JCI Insight. 2020. PMID: 32544099 Free PMC article.
-
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.Cytokine Growth Factor Rev. 2020 Aug;54:62-75. doi: 10.1016/j.cytogfr.2020.06.001. Epub 2020 Jun 2. Cytokine Growth Factor Rev. 2020. PMID: 32513566 Free PMC article. Review.
-
Hematological findings in coronavirus disease 2019: indications of progression of disease.Ann Hematol. 2020 Jul;99(7):1421-1428. doi: 10.1007/s00277-020-04103-5. Epub 2020 Jun 3. Ann Hematol. 2020. PMID: 32495027 Free PMC article. Review.
-
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.EBioMedicine. 2020 May;55:102763. doi: 10.1016/j.ebiom.2020.102763. Epub 2020 Apr 18. EBioMedicine. 2020. PMID: 32361250 Free PMC article.
-
Clinical and immunological features of severe and moderate coronavirus disease 2019.J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244. J Clin Invest. 2020. PMID: 32217835 Free PMC article.
Cited by
-
A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality.Viruses. 2024 May 20;16(5):810. doi: 10.3390/v16050810. Viruses. 2024. PMID: 38793691 Free PMC article.
-
Vascular Alterations Following COVID-19 Infection: A Comprehensive Literature Review.Life (Basel). 2024 Apr 24;14(5):545. doi: 10.3390/life14050545. Life (Basel). 2024. PMID: 38792566 Free PMC article. Review.
-
Weight loss treatment for COVID-19 in patients with NCDs: a pilot prospective clinical trial.Sci Rep. 2024 May 14;14(1):10979. doi: 10.1038/s41598-024-61703-1. Sci Rep. 2024. PMID: 38744929 Free PMC article. Clinical Trial.
-
Disseminated tuberculosis after Polatuzumab-Vedotin based chemoimmunotherapy in a patient with Burkitt's lymphoma.Clin Case Rep. 2024 May 7;12(5):e8838. doi: 10.1002/ccr3.8838. eCollection 2024 May. Clin Case Rep. 2024. PMID: 38721565 Free PMC article.
-
Association between baseline insulin resistance and hospital mortality in moderate-to-severe coronavirus disease 2019 patients without diabetes mellitus: An observational study.Int J Crit Illn Inj Sci. 2024 Jan-Mar;14(1):26-31. doi: 10.4103/ijciis.ijciis_41_23. Epub 2024 Mar 27. Int J Crit Illn Inj Sci. 2024. PMID: 38715756 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous